Skip to main content
TipRanks
Go Ultimate75% OFF

Chugai Pharmaceutical Co (4519N) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

4519N Analyst Ratings

Moderate Buy
10Ratings
6Buy4Hold0Sell
Based on 10 analysts giving stock ratings to Chugai Pharmaceutical Co in the past 3 months

4519N Stock 12 Month Forecast

Mex$943.95â–²(26.94% Upside)
Based on 10 Wall Street analysts offering 12 month price targets for Chugai Pharmaceutical Co in the last 3 months. The average price target is MXN 943.95 with a high forecast of MXN 1,277.18 and a low forecast of MXN 708.25. The average price target represents a 26.94% change from the last price of MXN 743.63.
Highest Price TargetMex$1,277Average Price TargetMex$943.95Lowest Price TargetMex$708.25

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for MX:4519N
Price TargetArticle
Citi Analyst forecast on MX:4519NUnknown AnalystNot RankedCitiMex$1,289→Mex$1,277buy71.75%UpsideReiterated10/29/26
Morgan Stanley Analyst forecast on MX:4519NUnknown AnalystNot RankedMorgan StanleyMex$969.49buy30.37%UpsideReiterated10/28/26
Goldman SachsMex$1,016buy36.62%UpsideReiterated10/20/26
Macquarie Analyst forecast on MX:4519NUnknown AnalystNot RankedMacquarieMex$882.41→Mex$847.58buy13.98%UpsideReiterated10/16/26
UBS Analyst forecast on MX:4519NUnknown AnalystNot RankedUBSMex$835.97→Mex$777.92hold4.61%UpsideReiterated10/14/26
JefferiesMex$928.86→Mex$708.25hold-4.76%DownsideReiterated09/29/26
Daiwa Analyst forecast on MX:4519NUnknown AnalystNot RankedDaiwaMex$1,033buy38.96%UpsideReiterated09/28/26
SBI Securities Analyst forecast on MX:4519NUnknown AnalystNot RankedSBI SecuritiesMex$1,103buy48.33%UpsideReiterated09/09/26
Nomura Analyst forecast on MX:4519NUnknown AnalystNot RankedNomuraMex$928.86→Mex$882.41hold18.66%UpsideReiterated09/01/26
Mizuho Securities Analyst forecast on MX:4519NUnknown AnalystNot RankedMizuho SecuritiesMex$957.88→Mex$824.36hold10.86%UpsideReiterated08/19/26
Bank of America Securities Analyst forecast on MX:4519NUnknown AnalystNot RankedBank of America SecuritiesMex$1,022→Mex$870.80hold17.10%UpsideReiterated08/14/26
BernsteinMex$1,138buy53.01%UpsideReiterated07/07/26
J.P. Morgan Analyst forecast on MX:4519NUnknown AnalystNot RankedJ.P. MorganMex$1,277buy71.75%UpsideReiterated05/27/26
SMBC Nikko Analyst forecast on MX:4519NUnknown AnalystNot RankedSMBC NikkoMex$1,103→Mex$1,242buy67.06%UpsideReiterated02/25/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PLSEPulse Biosciences
SLDBSolid Biosciences
RZLTRezolute
IMUXImmunic
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Chugai Pharmaceutical Co

3 Months
Seiji Wakao
Seiji WakaoJ.P. Morgan
Success Rate4/6 ratings generated profit
67%
Average Return
+9.65%

Copying Seiji Wakao's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +9.65% per trade.

1 Year
Tony Ren
Tony RenMacquarie
Success Rate3/5 ratings generated profit
60%
Average Return
-3.70%

Copying Tony Ren's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of -3.70% per trade.

2 Years
Seiji Wakao
Seiji WakaoJ.P. Morgan
Success Rate3/6 ratings generated profit
50%
Average Return
+0.20%

Copying Seiji Wakao's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +0.20% per trade.

4519N Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for 4519N
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy11122
Buy65766
Hold55663
Sell00000
Strong Sell00000
total1211141411

In the current month, 4519N has received 8 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. 4519N average Analyst price target in the past 3 months is 943.95.

4519N Financial Forecast

Mex$7Mex$8.25Mex$9.5Mex$10.75Mex$12Q1 2026Q3 2026Q4 2026
HighMex$10.07
ConsensusMex$9.30
LowMex$8.13

4519N Earnings Forecast

Next quarter’s earnings estimate for 4519N is MXN 9.30 with a range of MXN 8.13 to MXN 10.07. The previous quarter’s EPS was MXN 11.10. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

Mex$34.5BMex$38BMex$41.4BMex$44.9BMex$48.4BQ1 2026Q3 2026Q4 2026
HighMex$45.1B
ConsensusMex$40B
LowMex$34.5B

4519N Sales Forecast

Next quarter’s sales forecast for 4519N is MXN 40.01B with a range of MXN 34.49B to MXN 45.15B. The previous quarter’s sales results were MXN 48.35B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

4519N Stock Forecast FAQ

What is MX:4519N’s average 12-month price target, according to analysts?
Based on analyst ratings, Chugai Pharmaceutical Co’s 12-month average price target is Mex$943.95.
What is MX:4519N’s upside potential, based on the analysts’ average price target?
Chugai Pharmaceutical Co has 26.94% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Chugai Pharmaceutical Co a Buy, Sell or Hold?
Chugai Pharmaceutical Co has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 4 hold ratings and 0 sell ratings.
What is Chugai Pharmaceutical Co’s share price target?
The average share price target for Chugai Pharmaceutical Co is Mex$943.95. This is based on 10 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$1,277.18, and the lowest forecast is Mex$708.25. The average share price target represents a 26.94% increase from the current price of Mex$743.63.
What do analysts say about Chugai Pharmaceutical Co?
Chugai Pharmaceutical Co’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Street analysts.
How can I buy shares of Chugai Pharmaceutical Co?
To buy shares of MX:4519N, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.